The English Edition of Calmark’s Annual Report 2018 is published
Calmark Sweden AB’s Annual Report 2018 is now published in English and is available at the corporate website: https://www.calmark.se/eng/investors/reports-and-presentations
CEO Anna Söderlund comments:
"When Calmark now adds 2018 to the documents, we can look back on a successful year. A year that included rapid progress in the development project, listing on the Spotlight Stock Market, new share issue and a strong build-up of the organization in Calmark.
With a small, very committed and dedicated team, in 2018 we have managed to reach all the goals we set for the year. Together, we have even managed to stay ahead of schedule on certain parts of the project.”
For more information about Calmark Sweden AB, please contact:
Anna Söderlund, CEO
Telefon: +46 70 213 25 35
Calmark Sweden AB is a medical technology company developing a point-of-care (POC) analyzis method with easier and faster sampling of medical conditions in newborns. The unique test platform, which consists of a reader and single-use products, is expected to be ready for launch in 2020 when three important POC tests are introduced. The WHO estimates that 1.5 billion children will be born worldwide by 2030. In the Western world, the introduction of POC diagnostics is resulting in huge savings and shorter healthcare chains. In less developed healthcare systems, the product helps save lives. Calmark aims to become the global leader and ultimately to offer all relevant POC tests for the first period of life, regardless of where in the world a baby is born. Read more about Calmark www.calmark.se/eng/home.